The Latest Breaking News from Thermo Fisher Scientific

Thermo Fisher Scientific is poised to release its third-quarter results later this month, and analysts expect a single-digit earnings dip.

Thermo Fisher Scientific recently underperformed the healthcare sector, but Wall Street analysts are bullish about the stock’s prospects.

Thermo Fisher Scientific has underperformed relative to the broader market over the past year, yet analysts are bullish on the stock's potential.

Thermo Fisher Scientific shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81.

After leaving Congress, Reichert took up work as a lobbyist, urging foreign governments to adopt "Rapid DNA"

Although Thermo Fisher Scientific underperformed the Dow Jones Industrial Average over the past year, analysts remain optimistic about the company's future due to its increasing demand and strategic product launches.

Thermo Fisher stock shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Thermo Fisher Scientific and the Centre for Cellular and Molecular Platforms (C-CAMP) recently announced a collaborative initiative to establish a Centre of Excellence in Bengaluru. This state-of-the-art facility will serve as a hub for fostering innovation, accelerating breakthroughs in the biotechnology sector and enabling researchers to enhance their expertise and…

Thermo Fisher Scientific chopped its 2023 outlook for the second time this year, and TMO stock slumped, continuing a two-month sell-off.

With volatility at the lowest levels in two years, options are cheap so it’s a good time to check in on our bear put spread screener.

Aug. 1, 2023 would have been Henrietta Lacks’s 103rd birthday. It was also the day the Lacks family reached a settlement with Thermo Fisher Scientific, the biotech company that used and profited from her “HeLa” cells.